DUBLIN, November 27, 2017 /PRNewswire/ --
The "Global Tuberculosis (TB) Diagnostics Market 2017-2021" report has been added to Research and Markets' offering.
The analysts forecast the global tuberculosis (TB) diagnostics market to grow at a CAGR of 3.56% during the period 2017-2021.
Global Tuberculosis (TB) Diagnostics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
The latest trend gaining momentum in the market is Expansion of healthcare infrastructure. Healthcare infrastructure has constantly been expanding across the world. Efforts have also been made to make diagnostic facilities available in rural areas. People are encouraged to visit clinics or healthcare facilities in the vicinity to diagnose and treat diseases. This could reduce the burden of large test volumes from large hospitals. It would also reduce the burden of healthcare expenses rural and semi-urban populations. This is because out of pocket expense would decrease.
According to the report, one of the major drivers for this market is Increasing prevalence of TB. TB affects a significant proportion of the population each year. In 2015, it was one of the 10 major causes of death, ranking above acquired immunodeficiency syndrome (AIDS). However, TB can be cured through early diagnosis and treatment.
Further, the report states that one of the major factors hindering the growth of this market is Accessibility and cost constraints of advanced TB diagnostics. New and improved diagnostics can reform TB diagnostics. However, it is important to make them accessible in clinics when patients initially seek medical attention for TB. For instance, despite its various features, Xpert was not considered as a POC test.
- Focus on partnerships and acquisitions for product development
- Continuous technological advances
- Expansion of healthcare infrastructure
- F. Hoffmann-La Roche
- Thermo Fisher Scientific
Other prominent vendors
- Akonni Biosystems
- Ameritek USA
- Autobio Diagnostics
- EIKEN CHEMICAL
- GeTein BioMedical
- Hain Lifescience
- Ortho Clinical Diagnostics
- Siemens Healthineers
Key Topics Covered:
Part 01: Executive Summary
Part 02: Scope Of The Report
Part 03: Research Methodology
Part 04: Introduction
Part 05: Market Landscape
Part 06: Segmentation By Product Type
Part 07: Segmentation By End-User
Part 08: Segmentation By Geography
Part 09: Decision Framework
Part 10: Drivers And Challenges
Part 11: Market Trends
Part 12: Vendor Landscape
Part 13: Key Vendor Analysis
Part 14: Appendix
For more information about this report visit https://www.researchandmarkets.com/research/k95lhn/global
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets